GI pharmacology, amiodarone-like drugs and regulatory peptides.
Among other topics covered on the third day of the EPHAR meeting, a symposium was dedicated to the discussion of new trends in gastrointestinal (GI) pharmacology. In another session, the pharmacology and biology of serotonin receptors was discussed, highlighting the advances made in the discovery of receptor subtypes and their putative function. A particularly interesting and well-presented symposium was scheduled in the afternoon program, detailing the use of amiodarone-like agents in the treatment of cardiac arrhythmias; this session was sponsored by Sanofi-Synthelabo, with many presentations given by representatives from the company.